Ignite Creation Date:
2025-12-24 @ 11:30 PM
Ignite Modification Date:
2025-12-25 @ 9:18 PM
Study NCT ID:
NCT06133556
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-11-15
First Post:
2023-09-08
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Conditioning Regimen Containing Melphalan and Cladribine for Refractory / Relapsed AML
Sponsor:
Institute of Hematology & Blood Diseases Hospital, China
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-11-24
Start Date Type:
ESTIMATED
Primary Completion Date:
2028-10-20
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-10-20
Completion Date Type:
ESTIMATED
First Submit Date:
2023-09-08
First Submit QC Date:
None
Study First Post Date:
2023-11-15
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-11-13
Last Update Post Date:
2023-11-15
Last Update Post Date Type:
ACTUAL